spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Innocoll Pharmaceuticals 

 HSMN NewsFeed - 26 Sep 2022
Innocoll and DURECT Announce U.S. launch of POSIMIR(R)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 8 Mar 2010
EUSA Pharma Completes Establishment of Commercial Infrastructure With Appointment of President for Europe and International Region
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2009
Innocoll, Inc. Files 510 (k) Application for CollaRx Lidocaine Sponge
Devices Wound Care
 HSMN NewsFeed - 31 Mar 2009
EUSA Pharma Completes the European Launch of CAPHOSOL(R) for Prevention and Treatment of Oral Mucositis Caused by Cancer Therapy
Biopharmaceuticals
 HSMN NewsFeed - 25 Aug 2008
Baxter Announces Licensing Agreement for Innocoll's Gentamicin Surgical Implant in the United States
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 9 May 2008
EUSA Pharma Completes Acquisition Of Cytogen Corporation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Mar 2008
EUSA Pharma to Acquire US Specialty Oncology Company Cytogen
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Sep 2007
Innocoll, Inc. and Bourne Partners Announce Joint Venture to Build Leading U.S. Advanced Wound Care Business
Devices Wound Care
 HSMN NewsFeed - 8 Aug 2007
Health Canada Approves Innocoll's CollaRx(R) GENTAMICIN SURGICAL IMPLANT
Devices Regulatory
 HSMN NewsFeed - 22 Mar 2007
Innocoll Files CollaRx(R) GENTAMICIN SURGICAL IMPLANT in Canada and Receives Canadian Medical Devices Conformity Assessment System (CMDCAS) Certification
Devices Regulatory
 HSMN NewsFeed - 5 Feb 2007
Innocoll Receives BfArM Approval for a New Version of its CollaRx(R) Gentamicin Surgical Implant in Germany
Devices Surgery Regulatory
 HSMN NewsFeed - 22 Jan 2007
Innocoll Receives FDA Approval to Commence a Phase 2 Clinical Trial for the Topical Treatment of Infected Diabetic Foot Ulcers with Its CollaRx(R) GENTAMICIN
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Jan 2007
Innocoll Announces Expansion of Distribution Partnership for its CollaRx(R) GENTAMICIN SURGICAL IMPLANT With BurnsAdler to Include Brazil and Dominican Republic and a Separate Promotional Agreement Between BurnsAdler and Serral for Same Product in Mexico
Devices Distribution
 HSMN NewsFeed - 9 Nov 2006
Innocoll Announces Investigational New Drug Application Filing for its CollaRx GENTAMICIN as a Topical Treatment for Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 12 Oct 2006
Innocoll, Inc. Receives FDA Approval For CollaGUARD(TM), A Collagen-Based Advanced Wound Care Product
Devices Wound Care
Return to NewsFeed  

 Additional items found! 11

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 11 additional stories matching:
Innocoll Pharmaceuticals
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.